Ocular surface toxicity of depatuxizumab mafoditin (ABT-414): case reports.

The purpose of this study is to report the clinical features and outcomes of ocular surface toxicity following depatuxizumab mafoditin (ABT-414) therapy for unresectable glioblastoma. Ocular signs and symptoms of three patients treated with ABT-414 during a phase III trial for glioblastoma multiforme were evaluated. Both eyes of all patients were damaged during the week after the first infusion of the ABT-414 molecule.

Effect of blood flow restriction during low-intensity resistance training on bone markers and physical functions in postmenopausal women.

Background: The aim of this study was to investigate the effects of 12-week low intensity resistance training (RT) with blood flow restriction on bone mineral density (BMD), bone turnover markers (BTM), physical functions, and blood lactate concentration in postmenopausal women with osteoporosis or osteopenia.

Methods: 26 study participants (56 ± 1.8yrs, T-score: -2.